These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28324123)

  • 21. [Treatment of Paget's disease of bone with zoledronic acid].
    Body JJ; Sternon J
    Rev Med Brux; 2005; 26(6):513-7. PubMed ID: 16454155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D
    Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone.
    Cundy T; Maslowski K; Grey A; Reid IR
    J Bone Miner Res; 2017 Apr; 32(4):753-756. PubMed ID: 27808435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Paget's disease of bone: importance of the zoledronic acid].
    Griz L; Colares V; Bandeira F
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):845-51. PubMed ID: 17160207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Paget's disease of bone.
    Reid IR
    Osteoporos Int; 2020 May; 31(5):827-837. PubMed ID: 31848640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of a whole body index with bone scintigraphy to monitor the response to therapy in Paget's disease.
    Griffith K; Pearson D; Parker C; Thorpe S; Vincent RM; Hosking DJ
    Nucl Med Commun; 2001 Oct; 22(10):1069-75. PubMed ID: 11567178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronate treatment in active Paget's disease.
    Chung G; Keen RW
    Ann Rheum Dis; 2003 Mar; 62(3):275-6. PubMed ID: 12594123
    [No Abstract]   [Full Text] [Related]  

  • 28. The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone.
    Garnero P; Christgau S; Delmas PD
    Bone; 2001 May; 28(5):461-4. PubMed ID: 11344044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
    Polyzos SA; Anastasilakis AD; Anagnostis P; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
    Endokrynol Pol; 2012; 63(4):312-5. PubMed ID: 22933168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S; Pearson D; Hosking DJ
    Arthritis Rheum; 1995 Oct; 38(10):1506-12. PubMed ID: 7575701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paget's disease of the bone: a report of three cases.
    Bhatt K; Balakrishnan C; Mangat G; Bajan K; Ashavaid T; Joshi VR
    J Assoc Physicians India; 2006 Jul; 54():571-4. PubMed ID: 17089908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).
    Rendina D; Falchetti A; Diacinti D; Bertoldo F; Merlotti D; Giannini S; Cianferotti L; Girasole G; Di Monaco M; Gonnelli S; Malavolta N; Minisola S; Vescini F; Rossini M; Frediani B; Chiodini I; Asciutti F; Gennari L
    J Endocrinol Invest; 2024 Jun; 47(6):1335-1360. PubMed ID: 38488978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Paget's disease: case report].
    Wegierska M; Ignaczak P; Zalewska J; Jeka S
    Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D; Martínez-Morillo M; Holgado S; Erra A
    Med Clin (Barc); 2014 May; 142(10):469-70. PubMed ID: 24120108
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
    Ryan PJ; Gibson T; Fogelman I
    J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Paget's Disease of the Calcaneum.
    Humphrey J; Pervez A; Walker R; Abbasian A; Singh S
    J Foot Ankle Surg; 2017; 56(2):401-403. PubMed ID: 28089128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
    N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.